Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001209191-21-029066

Options or other derivatives

  • Chief Medical Officer acquired 35,675 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dawson Michael John Chief Medical Officer 2021-04-27 Grant or award · Stock Option (Right to Buy) +5,438 5,438 D
Dawson Michael John Chief Medical Officer 2021-04-27 Grant or award · Stock Option (Right to Buy) +20,391 20,391 D
Dawson Michael John Chief Medical Officer 2021-04-27 Grant or award · Stock Option (Right to Buy) +5,084 5,084 D
Dawson Michael John Chief Medical Officer 2021-04-27 Grant or award · Stock Option (Right to Buy) +1,962 1,962 D
Dawson Michael John Chief Medical Officer 2021-04-27 Grant or award · Stock Option (Right to Buy) +2,800 2,800 D
Loading xslF345X03/doc4.xml…